Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity

DOI: 10.5662/wjm.v6.i1.25

Keywords: Reovirus, Type 3 Dearing, Oncolytic virus, Ras, Epidermal growth factor receptor, Clinical trial, Preclinical, Immune modulation

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text